$2.30
0.135.99%
At close: Aug 25, 5:00 PM EST
$2.11
-0.19-8.26%
After Hours: Aug 24, 7:07 PM EST
Chemomab Therapeutics Ltd Earnings Estimates
CMMBNASDAQ
Earnings: Q2 2026 Earnings were released on Wed Aug 19th, before the market open
Chemomab Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CMMB
Chemomab Therapeutics (CMMB) is scheduled to report Q3 earnings on November 19, 2026. Analysts estimate EPS of $-0.04 and quarterly revenue of N/A.
In the most recent quarter (Q2), Chemomab Therapeutics reported EPS of $-0.27, missing estimates of $-0.08 by 2.38%. Revenue came in at $0, meeting the estimate of $0 by 0%.
Chemomab Therapeutics has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Chemomab Therapeutics has averaged an EPS surprise of 1.89% and a revenue surprise of 0%.
Earnings Date
Nov 19
EPS Estimate
$-0.040
Quarterly Revenue Estimate
–
Annual Revenue
–
as of Jun 30
Chemomab Therapeutics Earnings History
Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.
Chemomab Therapeutics (CMMB) Earnings Per Share
The chart below shows Chemomab Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Chemomab Therapeutics (CMMB) Revenue
The chart below shows Chemomab Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?
Chemomab Therapeutics (CMMB) is scheduled to report earnings on November 19, 2026. The last reported earnings were for reported on August 19, 2026 for Q2.
What were the latest earnings per share (EPS) for Chemomab Therapeutics (NASDAQ:CMMB)?
The Actual EPS was $-0.27, which missed the estimate of $-0.08.
What were Chemomab Therapeutics’s (NASDAQ:CMMB) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
